Patent ID: 11919907
Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 18:
19. A method of treating a disease or disorder that is beneficially treated by inhibiting the activity of a JAK in a human subject in need thereof, comprising administering to the human subject an effective amount of a pharmaceutical composition comprising: (i) a first JAK inhibitor which is a compound represented by structural Formula (I), or a pharmaceutically acceptable salt thereof,
wherein,
Y1 is selected from hydrogen and deuterium;
each Y2 is selected from hydrogen and deuterium; and
each Y3 is selected from hydrogen and deuterium
wherein each position designated specifically as deuterium has at least 90% deuterium incorporation; (ii) a second JAK inhibitor; and (iii) a pharmaceutically acceptable carrier.